Natalia Marina CARDILLO | Drug Discovery and Development | Best Researcher Award

Natalia Marina CARDILLO | Drug Discovery and Development | Best Researcher Award

Dr. Natalia Marina CARDILLO, USDA-ARS-WSU, United States

Dr. Natalia Marina Cardillo is a distinguished veterinary scientist from Argentina with a Ph.D. in Veterinary Sciences, specializing in parasitology and public health 🧫. Currently a Postdoctoral Research Associate at Washington State University πŸ‡ΊπŸ‡Έ, she focuses on chemotherapeutic strategies for bovine babesiosis. With over two decades of academic and research excellence across UBA, CONICET, INTA, and USDA, she has led groundbreaking projects on zoonoses, antiparasitic drug resistance, and diagnostics. 🧬 Her contributions span teaching, diagnostics, and pharmaceutical clinical trials in veterinary medicine, earning her global recognition and prestigious fellowships.

Publication Profile

Google Scholar

Education

Dr. Natalia Marina Cardillo began her academic path with a Doctor of Veterinary Medicine degree (1997–2004) from the Universidad de Buenos Aires, Argentina, specializing in Public Health πŸ•β€πŸ¦ΊπŸ©Ί. She furthered her expertise by completing a Ph.D. in Veterinary Sciences with a focus on Parasitology and Public Health (2006–2012), earning the prestigious β€œsumma cum laude” distinction for her thesis on Toxocara cati in murine models 🧬🧫. To complement her academic and research proficiency, she pursued a University Teaching Major in Veterinary and Biological Sciences (2014–2016), strengthening her role as an educator and mentor πŸ“šπŸ‘©β€πŸ«.

Experience

Dr. Natalia Marina Cardillo has led a distinguished career in parasitology, veterinary microbiology, and public health. Currently a Postdoctoral Research Associate at Washington State University πŸ„πŸ’Š, she focuses on developing novel treatments for bovine babesiosis. Previously, she served as Senior and Principal Scientist at CONICET-INTA πŸ‡¦πŸ‡·, leading studies on zoonotic parasitic diseases. With over two decades of academic roles at the Universidad de Buenos Aires πŸ‘©β€πŸ«πŸ§«, she also contributed significantly to diagnostics, laboratory accreditation, and veterinary clinical trials. As founder of ALIANZA InVet πŸ§¬πŸ•, she has pioneered ethical animal research and advanced pharmaceutical testing across Argentina.

Awards

Dr. Natalia Marina Cardillo has received numerous prestigious honors throughout her career. From 2023 to 2025, she was awarded a competitive Postdoctoral Fellowship by the USDA at Washington State University πŸ‡ΊπŸ‡ΈπŸ”¬. In 2018, she won the NAVES entrepreneurship competition by Universidad Austral’s IAE Business School for her CRO-VET project πŸ…πŸ’Ό. Her academic excellence was recognized early with a Ph.D. fellowship (2005–2010) in Public Health Veterinary Medicine and a Scientific Research Scholarship (2000–2002) in Parasitology at Universidad de Buenos Aires πŸ‡¦πŸ‡·πŸ“˜β€”highlighting her dedication to veterinary science and innovation.

Research Focus

Dr. Natalia Marina Cardillo’s research is rooted in veterinary parasitology, with a strong emphasis on zoonotic diseases, public health, and epidemiology πŸ›πŸ§«πŸŒ. Her work investigates parasites like Toxocara cati, Trichinella spp., and Aelurostrongylus abstrusus, exploring their life cycles, transmission, and pathology in animal hosts and their public health implications πŸ’‰πŸ“Š. She also focuses on developing chemotherapeutic treatments for diseases such as bovine babesiosis, integrating pharmacology, immunology, and molecular diagnostics πŸ§¬πŸ’Š. Her interdisciplinary research contributes significantly to One Health, bridging human, animal, and environmental health.

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. πŸ“šπŸ’ŠπŸ§ πŸ”¬πŸ‘¨β€πŸ”¬

Publication Profile

Google Scholar

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. πŸ“šπŸ’ŠπŸŽ“

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. πŸ”¬πŸ§ πŸ’ŠπŸ¦ πŸ’‘

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. πŸ“šπŸ’ŠπŸ‘¨β€πŸ«

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. πŸ†πŸ“š This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. πŸŒŸπŸ’Š With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. πŸš€πŸ”¬ His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. πŸŒ±πŸŽ“

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities πŸ§ͺ🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential πŸ„πŸ”¬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments πŸŒŸπŸ“–.

Publication Top Notes

Alkylating agents, the road less traversed, changing anticancer therapy

Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design

Exploring the pharmacognostic properties and pharmacological activities of phytocompounds present in Ficus racemosa linn.: A concise review

A molecular insight into pyrazole congeners as antimicrobial, anticancer, and antimalarial agents

Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective

In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica charantia